MoneyShow presents top investment ideas for 2026 from leading advisors. Part 9 includes Target Corp., The Trade Desk, UFP ...

Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...

The Philippine version of 'A Werewolf Boy' is racing down the box office road as soon as it opened. The film 'A Werewolf Boy,' produced by Viva Communications, the Philippines' largest entertainment ...

This opens the door to making mistakes—ones that could worsen your side effects, affect how much weight you’ll lose, or even ...

Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold ...

As GLP-1 pills for weight loss enter the U.S. market, some pharmaceutical companies are testing the possibility of a gene therapy to stimulate GLP-1 production, The Washington Post reported Jan. 24.

GLP‑1 weight‑loss drugs are reshaping food industry demand, but side effects, cost barriers and unclear long‑term impacts ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

A once-weekly injectable glucose-dependent insulinotropic polypeptide/GLP-1 dual agonist conferred up to 14.7% weight loss at ...

The use of GLP-1 receptor antagonist therapy has led to a greater reduction in colorectal cancer incidence than has been ...

Diabetes care is undergoing a major transformation driven by GLP-1 receptor agonists, which have expanded beyond glycemic ...

By Tarun Sai Lomte An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing ...